Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.0 - $15.9 $0 - $766,682
48,219 New
48,219 $0

Others Institutions Holding MNKPF

# of Institutions
1
Shares Held
35K
Call Options Held
0
Put Options Held
0

About Mallinckrodt plc


  • Ticker MNKPF
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,170,900
  • Description
  • Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in...
More about MNKPF
Track This Portfolio

Track Cyrus Capital Partners, L.P. Portfolio

Follow Cyrus Capital Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cyrus Capital Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Cyrus Capital Partners, L.P. with notifications on news.